Filing Flows › Mesa Laboratories (MLAB) › Q2 FY27 › vs Q1 FY27
Mesa Laboratories (MLAB) Q2 FY27 vs Q1 FY27 (quarter over quarter)
Mesa Laboratories's revenue rose $2.2M (+4%) from $60.1M in Q1 FY27 to $62.3M in Q2 FY27. Gross margin 64.0% against 64.9% (-0.9 pts).
Mesa Laboratories, Q2 FY27: revenue $62.3M (+3% year over year), operating margin 13.5%, net earnings $4.3M, operating cash flow $4.1M. The chart draws each line against Q1 FY27, the increases inside each band.
Margins
| Q2 FY27 | Q1 FY27 | Change | |
|---|---|---|---|
| Gross margin | 64.0% | 64.9% | -0.9 pts |
| Operating margin | 13.5% | 11.7% | +1.8 pts |
| Net margin | 7.0% | 4.7% | +2.3 pts |
| Free cash flow margin | 6.0% | 23.6% | -17.6 pts |
Every line
| Line | Q2 FY27 | Q1 FY27 | Change | % |
|---|---|---|---|---|
| Revenue | $62.3M | $60.1M | $2.2M | +4% |
| Gross profit | $39.9M | $39.0M | $866K | +2% |
| Cost of revenue | $22.5M | $21.1M | $1.3M | +6% |
| Operating profit | $8.4M | $7.0M | $1.4M | +19% |
| Operating expenses | $31.5M | $32.0M | −$491K | -2% |
| Pre-tax earnings | $6.0M | $4.4M | $1.7M | +39% |
| Other expense, net | $2.4M | $2.7M | −$324K | -12% |
| Research & development | $5.1M | $4.7M | $326K | +7% |
| Sales & marketing | $9.8M | $9.9M | −$47K | -0.5% |
| General & admin | $16.6M | $17.4M | −$770K | -4% |
| Net earnings | $4.3M | $2.8M | $1.5M | +53% |
| Income tax | $1.7M | $1.5M | $170K | +11% |
| Operating cash sources | $13.3M | $10.8M | $2.4M | +23% |
| Depreciation & amortization | $5.6M | $5.6M | −$84K | -1% |
| Share-based compensation | $3.4M | $2.4M | $1.0M | +43% |
| Working capital & other | $9.2M | −$3.9M | $13.1M | — |
| Operating cash flow | $4.1M | $14.7M | −$10.6M | -72% |
| Free cash flow (OCF − capex) | $3.7M | $14.2M | −$10.5M | -74% |
| Capital expenditures | $387K | $559K | −$172K | -31% |
Questions
How much did Mesa Laboratories's revenue grow quarter over quarter in Q2 FY27?
Mesa Laboratories's revenue rose $2.2M (+4%) from $60.1M in Q1 FY27 to $62.3M in Q2 FY27. Gross margin 64.0% against 64.9% (-0.9 pts).